Study title: Safety and tolerabilty or oral pantoprazole in subjects aged 12 to 16 years with symptomatic GERD ; efficacy (treatment outcome). Outpatient, randomized; double-blind, parallel-treatment group study.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Digestive System Diseases | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: PANTOPRAZOLE | |||||
ATC code: A02BC02 | |||||
Document link: | |||||
Document date: | |||||
Study number: 3001A1-326-US | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | Y |